Archive | education & training RSS for this section

Une version française du cours de formation de CITI sur la division 5 est maintenant disponible; les institutions du C17 ont accès via l’inscription du C17 au N2

Remarque: Le C17 est membre N2 (Réseau des Réseau): les institutions du C17 ont accès à toutes les ressources d’enseignement et de formation N2, y compris la formation  CITI.

Le Cours de CITI sur la Division 5: Drogues destinées aux essais cliniques sur des sujets humains de Santé Canada a été traduit en français. Cette traduction a été possible grâce a l’aide financière généreusement offerte par le FRSQ. Vous pouvez y accéder en consultant le site Web de CITI: http://n2canada.us14.list-manage2.com/track/click?u=3701881b24851f487859ab8c8&id=b17362d464&e=33118d4f3d.

The Health Canada Division 5: Drugs for Clinical Trials Involving Human Subjects CITI Course has been translated into a French version. The FRQS has generously provided financial support to make this translation possible. It can now be accessed through the CITI website: http://n2canada.us14.list-manage2.com/track/click?u=3701881b24851f487859ab8c8&id=fc3e54cb50&e=33118d4f3d.

 

SAVE-THE-DATE: C17 “Next Generation of Early Phase Trials: Moving the Bar in Pediatric Oncology” educational workshop (Saturday, 4 November 2017)

C17 “Next Generation of Early Phase Trials: Moving the Bar in Pediatric Oncology educational workshop being held on Saturday, 4 November 2017 in Vancouver, BC. The workshop is in response to the C17 DVL needs assessment that was completed last year as we expanded the C17 DVL network across Canada from 8 to 11 sites. While many investigators and research staff have had experience or education in early phase trials, here was a need identified to provide education and mentorship to research staff conducting early phase trials. With the development of pediatric precision medicine trials in Canada, the need will be even greater.

The workshop is a full day, pre-session workshop at the CCRA Canadian Cancer Research Conference. We hope that most attendees at our workshop will take the opportunity to attend the full conference as well.

The workshop will be designed to educate investigators on traditional models of early phase trials as well as newer approaches to drug development. We will also cover regulatory, ethical, advocacy and access aspects of early phase trials. The workshop will proved education, discussions, panels and time for questions.

Our goal will be to help provide some funding to C17 DVL participating centres to allow investigators and senior research staff to attend.

 

More details will be circulated once available.

 

C17 Education Rounds Videoconference: The Hospital at Home (H@H) Program by Dr. Lucie Lafay-Cousin

The Hospital at Home (H@H) Program at the Alberta Children’s Hospital

Dr. Lucie Lafay-Cousin MD, Pediatric Oncologist, Alberta Children’s Hospital

Wednesday March 15, 2017, 12:00 – 13:15 MST

Objectives:

  1. Describe the H@H initiative
  2. Report on activities and results
  3. Discuss the practical aspects of program development

This event will be recorded by AHS Digital Media Services and will be available to view after the presentation date. 

Telehealth host site: Stollery Children’s Hospital

Telehealth Registration:  Book a room with your institution’s Videoconference Dept. and then follow instructions in the e-mail included with this poster (see e-mail below) in order to register online with Alberta Health Services @ www.vcscheduler.ca/ahs
If you need help please contact our Telehealth team atedm.telehealthscheduling@albertahealthservices.ca

 

To obtain credit certification, please make sure you complete and submit your evaluation form.

Release of CCTCC REB Accreditation WG Final Recommendations & Joint Response by CCTCC & Health Canada

The purpose of this message is to introduce the CCTCC REB Accreditation WG’s Final Recommendations (FRs), and the joint response by the CCTCC and Health Canada (HC) to the FRs.
The full package is available HERE.

CCTCC REB WG FRs:

There are seven FRs in total, aimed at ensuring Canada’s REB competitiveness on a global scale. FR#7, which calls for the establishment of a National Strategic Leadership Forum, is seen as the foundation of the other FRs. The FRs are based on data collected through interviews with key stakeholders in the Canadian and US REB fields as well as consultations and feedback provided by key REB stakeholders in Canada.

Background:

The CCTCC REB Accreditation WG was established in 2015, in collaboration with Health Canada, to identify strategies to improve efficiencies of ethics reviews and advance strategic issues like accreditation in regards to clinical trials. The establishment of the WG is consistent with Recommendation #4 of the Action Plant to Help Attract More Clinical Trials to Canada as well as Recommendation #3 of the Senate Report entitled “Canada’s Clinical Trials Infrastructure: A prescription for Improved Access to New Medicines”.

Given the REB centralization and harmonization initiatives that have been taking place across Canada, the WG, as stated in their Interim Report (IR), did not see formal accreditation scheme as a given. The IR’s key recommendations called for investigating the:

  • impact of these provincial initiatives
  • models of review being adopted by these initiatives,
  • standards and metrics currently being applied to REB operations (in Canada and USA)

The WG proceed with addressing the IR’s recommendations which resulted in the presented/attached FRs.

The contents of the full package include:

  1. Summary of the FRs and joint response by CCTCC and HC
  2. Full text of the FRs
  3. SPOR SHRER Report Committee recommendations – in fulfillment of FR I

CCTCC and Health Canada wish to express their profound gratitude to the members of the REB Accreditation Working Group (WG) and specifically the chair of the WG – Laurel Evans and the co-chair Karine Morine for their continued dedication and invaluable efforts in making the attached report a reality.

Please direct any questions to Elena Aminkova, Interim Director of Project Facilitation, CCTCC by emailing eaminkova@cctcc.ca

Biospecimen Research Methods – UBCx online professional course begins February 15

Enrollment is now open! Class begins February 15, 2017.

Biospecimen Research Methods is a UBCx online professional education course offered from http://www.edx.org. This course will help you transform the quality of your research by teaching you the biobanking best practices to collect, store and use human biospecimens in the laboratory.

This course is designed for researchers including graduate and undergraduate students, postdoctoral fellows, pathology residents and research technicians who work with human biospecimens.

Over 6 weeks, professionals with extensive experience in biobanking from the University of British Columbia and the British Columbia Cancer Agency will teach you the international best practices for biobanking and research involving human biospecimens, based on National Cancer Institute (NCI) and International Society of Biological Environmental Repositories standards (ISBER).

What you’ll learn

  • Develop the knowledge to better collect and process human biospecimens to enhance research credibility
  • How to plan a successful research study using biospecimens
  • How to properly store and manage biospecimen data
  • Understand the ethical and privacy issues related to biobanking
  • Gain applicable hands on techniques related to informed consent, data queries, biospecimen collection and storage

Learn more about  Biospecimen Research Methods and enroll today!

www.edx.org/course/biospecimen-research-methods-ubcx-biobank1x

Norma Auger Education Fund – Applications due May 2017

The goal of the C17 Norma Auger Education Fund is to support health professionals involved in pediatric Oncology/Hematology/BMT across Canada advance their knowledge, skills and experience and to promote presentations and knowledge translation by these health professionals.

This is an annual scholarship offered by the C17 Education Committee with funding from the Childhood Cancer Canada Foundation and the Coast to Coast Against Cancer Foundation.
Eligibility:  Non-MD Pediatric Oncology/Hematology/BMT health care professionals working in Canada.

Application deadline: Monday, May 8, 2017.

Application forms can be downloaded HERE.

Travel conference funds for non-MD Canadian health care professionals: 2016 17 Norma Auger Education Fund applications due November 1

Application form: 2016 Norma Auger Application

The goal of the C17 Norma Auger Education Fund is to support health professionals involved in pediatric Oncology/Hematology/BMT across Canada advance their knowledge, skills and experience and to promote presentations and knowledge translation by these health professionals.  This is an annual scholarship offered by the C17 Education Committee with funding from the Childhood Cancer Canada Foundation and the Coast to Coast Against Cancer Foundation.

Eligibility:  Non-MD Pediatric Oncology/Hematology/BMT health care professionals working in Canada.

Application deadline:  Tuesday, November 1, 2016.

Selection Process: Applications will be reviewed by the C17 Education Committee.  Successful applicants will be notified in writing.

ACRP Announces Unrestricted Public Access to ‘Introduction to Clinical Trials’ Training Program. Suitable for staff (1.0 CBRN, ACCME), students and families.

Free Program to Help Develop Competence in Clinical Research Workforce and Raise Awareness of Clinical Trials

Washington, DC – The Association of Clinical Research Professionals (ACRP) announced immediate availability of a free educational program, “Introduction to Clinical Trials.”

Introduced at DIA 2016 in Philadelphia, PA, last month, Introduction to Clinical Trials provides fundamental education about the role clinical research plays in advancing medical knowledge and the work conducted by clinical research professionals.

The course details how medical products are developed, how volunteer patients are protected, and who plays key roles in the development, research, review, and approval of medical products. The one-hour online program also explores how historical studies have laid the path for creation, revision, and enforcement of the ethical principles and guidelines governing today’s clinical trials.

“ACRP is proud to offer this fundamental education in support of our mission to promote excellence in clinical research,” says Jim Kremidas, ACRP Executive Director. “As the leader in clinical research workforce development, providing those new to the profession with a core understanding of clinical research is a critical initiative for ACRP. We are thrilled to be able to freely provide this program to individuals, clinical trial sites, contract research organizations, and trial sponsors and suppliers. Thank you to Labconnect LLC for providing ACRP the educational grant to develop this program.”

Introduction to Clinical Trials is an ideal program for novice clinical researchers, including investigators, coordinators, and trial monitors, to develop the foundational knowledge upon which they can develop their competence as clinical research professionals. The program is also perfect for those interested in the profession or indirectly involved in clinical trials.

Introduction to Clinical Research is immediately available for free individual use through ACRP’s Learning Management System (LMS) here. The SCORM-compliant program can also be hosted on organizational Learning Management Systems. Contact Jenna Rouse, ACRP Director of Business Development, at jrouse@acrpnet.org or +1.703.254.8109 for information.

In addition to supporting clinical research professionals and organizations, this program is an ideal tool for organizations seeking to help educate the public about clinical research and to raise awareness of clinical trials and the clinical research profession.

“We welcome everyone looking to spread the word about clinical research to leverage this resource, including the academic institutions and other associations around the world educating those who will ultimately become the workforce of tomorrow,” says Kremidas.

Introduction to Clinical Trials is accredited by the Accreditation Council for Continuing Medical Education to provide 1 Continuing Medical Education credit for physicians, and by the California Board of Registered Nursing to provide 1 contact hour of continuing nursing education credit.

Continuing Nursing Education

The California Board of Registered Nursing approves the Association of Clinical Research Professionals (ACRP) as a provider of continuing nursing education. This live activity provides 1.0 contact hours of continuing Nursing education credit (Program Number 11147-2016-ICR-100).

Accreditation Council for Continuing Medical Education

The Association of Clinical Research Professionals (ACRP) is accredited by the Accreditation Council for Continuing Medical Education to provide Continuing Medical Education for physicians.

The Association of Clinical Research Professionals designates this live activity for a maximum of 1.0 AMA PRA Category 1 credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity.
CME Program Number: 0007229-2016-ICR-100

ACCME Physician Attributes

  • Work in interdisciplinary teams – cooperate, collaborate, communicate, and integrate care in teams to ensure that care is continuous and reliable
  • Apply quality improvement – identify errors and hazards in care; understand and implement basic safety design principles, such as standardization and simplification; continually understand and measure quality of care in terms of structure, process, and outcomes in relation to patient and community needs; and design and test interventions to change processes and systems of care, with the objective of improving quality
  • Employ evidence-based practice – integrate best research with clinical expertise and patient values for optimum care, and participate in learning and research activities to the extent feasible

Subject Matter Expert Developers

  • Eric Hayashi, President & CEO, Labconnect, LLC
  • James Chrisman, Labconnect, LLC

About ACRP

ACRP supports clinical research professionals through membership, training and development, and certification. Founded in 1976, ACRP is a Washington, DC-based nonprofit organization with more than 13,000 members who work in clinical research in more than 70 countries. ACRP’s vision is that clinical research is performed ethically, responsibly, and professionally everywhere in the world. ACRP’s mission is to promote excellence in clinical research. www.acrpnet.org

CONTACT:
Jovan Petty
+ 1.703.258.3520
media@acrpnet.org

Biannual Pediatric onc/hem education workshop in BC (Oct 28-29) for physicians, allied health professionals, residents and students

The BC Provincial Pediatric Oncology/Hematology Network along with BC Children’s Hospital Division of Oncology/Hematology/BMT will be hosting the biannual pediatric oncology hematology education day: Innovation, Inspiration and Engagement. 

 

It will be held at the Chan Center, BC Children’s Hospital on Oct 27 and 28, 2016. The format is: workshop on the evening of Oct 27 and full day on Oct 28. This Education Day is for all health care professionals involved in the care of pediatric oncology/hematology patients and their families. Two keynote talks are:  When Parents and Providers disagree: understanding and responding to conflicts in the care of children will be presented by Dr. Doug Diekema (attending physician and director of education for the Treuman Katz Center for Pediatric Bioethics at Seattle Children’s Hospital and professor in the Department of Pediatrics at the University of Washington School of Medicine) and The Highs and Lows of Cannabis, presented by Drs. Philip Crowell and Rod Rassekh.

Please visit the following website for full agenda and information on the education day.  http://ubccpd.ca/course/pediatric-oncology-hematology-education-day   

Registration is now open. Early bird ends on Monday, Sept 26, 2016.

C17 Education Rounds–Considering Adolescent Oncology Voice in Knowledge Mobilization: Implications for Practice

Andrea Johnson, RSW, PhD(c), Social Worker, Oncology/Hematology/BMT Program,  BC Children’s Hospital

Wednesday May 25, 2016, 12:00 – 13:00 MST

Objectives:

  1. To present adolescent voice as epistemology
  2. To argue it’s relevance for adolescent oncology
  3. To consider what this approach might look like in practice

This event will be recorded by AHS Digital Media Services and will be available to view after the presentation date. The link will be sent by e-mail for those who cannot attend on the date of the videoconference.

Telehealth host site: Stollery Children’s Hospital

Telehealth Registration:  Book a room with your institution’s Videoconference Dept. and then follow instructions in the e-mail included with this poster (see e-mail below) in order to register online with Alberta Health Services @ www.vcscheduler.ca/ahs
If you need help please contact our Telehealth team atedm.telehealthscheduling@albertahealthservices.ca

 

To obtain credit certification, please make sure you complete and submit your evaluation form.